INO 5401 Vaccination in BRCA1/2 Mutation Carriers
Clinical trial NCT04367675 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04367675
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2026-12-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.